Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/13783

Dimethoxane: Target Organs and Levels of Evidence for TR-354

Toxicology and Carcinogenesis Studies of Dimethoxane (CASRN 828-00-2) (Commercial Grade) in F344/N Rats and B6C3F1 Mice (Gavage Studies)

Chemical (Study Title)
CASRN		Peer Review DateRoute/Exposure LevelsStudy Laboratory
Dimethoxane
828-00-2		10/03/1988Gavage
MR: 0,62.5,125, FR: 0,125,250, M: 0,250,500 MG/KG/60 PER GROUP		Battelle Columbus Laboratory

Levels of Evidence

Male Rats: No Evidence
TypeOrgan/Tissue (Lesion)
Non-Neoplastic Lesions
  • FORESTOMACH: ACANTHOSIS 5/50 9/50 23/50; HYPERKERATOSIS 1/50 0/50 10/50
Female Rats: No Evidence
TypeOrgan/Tissue (Lesion)
Non-Neoplastic Lesions
  • FORESTOMACH: ACANTHOSIS 0/50 8/50 44/50; HYPERKERATOSIS 0/50 5/50 22/50
Male Mice: Equivocal Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Forestomach: SQUAMOUS CELL PAPILLOMA 2/47 3/47 7/50 OR SQUAMOUS CELL CARCINOMA 0/47 0/47 1/50 COMBINED 2/47 3/47 8/50
Non-Neoplastic Lesions
  • FORESTOMACH: ACANTHOSIS 2/47 4/47 20/50; HYPERKERATOSIS 1/47 1/47 23/50; HYPERPLASIA 2/47 7/47 11/50; INFLAMMATION, CHRONIC 0/47 0/47 5/50
Female Mice: No Evidence
TypeOrgan/Tissue (Lesion)
Non-Neoplastic Lesions
  • FORESTOMACH: ACANTHOSIS 0/49 5/48 23/48; HYPERKERATOSIS 0/49 4/48 27/48; HYPERPLASIA 3/49 14/48 22/48; INFLAMMATION, CHRONIC 0/49 0/48 1/48